SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

QTTB is trending due to news of a significant deal involving the sale of an asset, potentially leading to a stronger balance sheet and extended cash runway. The community is drawing comparisons to other high-flying stocks like $SMX and speculating about a potential short squeeze, focusing on its low float and substantial contract value. Discussions include potential price targets and the possibility of a major breakout.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending due to the closing of its asset purchase and licensing agreement with Novo Nordisk, sparking community excitement and speculation about future catalysts. Community members are also discussing the potential for FDA approval of Narsoplimab, with varied estimates of buyout prices and the impact of approval or rejection. The deal provides Omeros with significant upfront payments and potential milestones, as well as tiered royalties on net sales.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is trending due to a substantial cash tax refund received from the IRS, significantly boosting the company's liquidity. Community discussions revolve around the impact of this cash infusion on Wolfspeed's financial stability and its ability to fund expansion in key markets like EVs and AI, though concerns about profitability persist.

This is the in-game currency for the Crypto Raiders game. Players use it to recruit new characters, purchase characters and items in the in-game marketplace, and run more difficult dungeons.

Raider Aurum

Raider Aurum ($AURUM) is trending downwards amid heavy selling pressure and a deteriorating market outlook. The community is observing broken support levels and increasing downside volatility, suggesting a bearish trend continuation as shorts gain strength.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy (MSTR) is trending as it navigates Bitcoin's price volatility, impacting its balance sheet and future outlook. The community is debating the implications of Strategy establishing a $1.44 billion cash reserve and potential scenarios where it might need to sell its Bitcoin holdings. Discussions also include mNAV ratios and the impact of potential index changes, reflecting concerns about Strategy's correlation with Bitcoin's performance.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Gold is trending due to positive sentiment around gold's recent surge and anticipation of strong Q3 earnings, including an increased dividend and share buyback program. The community is also discussing Barrick's potential acquisition of Newmont's Nevada gold assets and the implications of a potential company split, speculating about value unlocking. Broader economic concerns and geopolitical uncertainty are driving interest in gold as a safe-haven asset, further fueling discussions around Barrick's future.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as the community anticipates upcoming earnings and speculates on potential moves by key figures like Michael Burry. Discussions revolve around the company's cash position, potential for a short squeeze, and the possibility of a share buyback. Some traders point to technical indicators suggesting upward momentum, while others remain cautious, citing past volatility and potential dilution.

Synopsys, Inc. engages in the provision of electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). It also offers semiconductor intellectual property (IP) products. It operates through the following segments: Design Automation, Design IP, and Software Integrity. The Design Automation segment includes silicon design, verification products and services, system integration products and services, digital, custom, and FPGA IC design software, verification software and hardware products, and manufacturing software products. The Software Integrity segment includes a solution for building security and compliance testing into the customers' software development lifecycle and supply chain. The company was founded by Aart J. de Geus, Bill Krieger, Dave Gregory, and Rick Rudell in December 1986 and is headquartered in Sunnyvale, CA.

Synopsys, Inc.

Synopsys Inc

Synopsys is trending due to Nvidia's $2 billion investment, sparking discussions about the strengthened partnership and its impact on AI-powered chip design. Community members are debating whether the deal is a positive catalyst or a dilution of shares. This news highlights Synopsys' pivotal role in the semiconductor industry as AI complexity continues to grow.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending amid a Bitcoin price correction, with discussions focused on whether this dip presents a buying opportunity or signals a longer-term downturn. Community members are debating potential support levels and analyzing whale activity, as well as considering the broader implications of BlackRock's ETF flows on market sentiment. Talk surrounds Microstrategy's exposure and influence, alongside commentary regarding market manipulation.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as investors debate the direction of interest rates amid economic uncertainty and a government shutdown, potentially impacting the Fed's rate decisions. Community discussions revolve around long-term bond strategies, the possibility of a Fed pivot, and the impact of potential economic slowdowns. Some traders express skepticism about bonds as a safe haven asset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$JNJ&#39;s oncology ambitions: Is $50B sales by 2030 realistic? 🤔

🔬 Oncology sales surged 20.6% in the first nine months, driven by market growth &amp; contributions from drugs like Darzalex, Erleada, and new launches.
💡 New FDA-approved drug Inlexzoh &amp; M&amp;A with Halda Therapeutics enhance the broader pipeline.

Discover if JNJ can double sales in the next 5-6 years here 👉 https://www.zacks.com/stock/news/2797167/jnjs-oncology-momentum-builds-as-it-chases-50b-goal-by-2030?cid=sm-stocktwits-2-2797167-body-22726&amp;ADID=SYND_STOCKTWITS_TWEET_2_2797167_BODY_22726

Zacks

Pardon Our Interruption

Zacks Research

Johnson & Johnson

's oncology ambitions: Is $50B sales by 2030 realistic? 🤔

🔬 Oncology sales surged 20.6% in the first nine months, driven by market growth & contributions from drugs like Darzalex, Erleada, and new launches.
💡 New FDA-approved drug Inlexzoh & M&A with Halda Therapeutics enhance the broader pipeline.

Discover if JNJ can double sales in the next 5-6 years here 👉 

This account is recognized as an Official Stocktwits Research Partner — working in close collaboration with Stocktwits to deliver in-depth research and market analysis.